160 related articles for article (PubMed ID: 22199321)
1. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S
Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis.
Gottschling S; Jensen K; Warth A; Herth FJ; Thomas M; Schnabel PA; Herpel E
Eur Respir J; 2013 Mar; 41(3):656-63. PubMed ID: 22743677
[TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E
Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770
[TBL] [Abstract][Full Text] [Related]
4. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
Li F; Zeng H; Ying K
Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
8. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
9. The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP).
Gottschling S; Herpel E; Eberhardt WE; Heigener DF; Fischer JR; Köhne CH; Kortsik C; Kuhnt T; Muley T; Meister M; Bischoff HG; Klein P; Moldenhauer I; Schnabel PA; Thomas M; Penzel R
Lung Cancer; 2012 Jul; 77(1):183-91. PubMed ID: 22483783
[TBL] [Abstract][Full Text] [Related]
10. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis.
Wang W; Chen Y; Deng J; Zhou J; Zhou Y; Wang S; Zhou J
Tumour Biol; 2014 Oct; 35(10):9769-75. PubMed ID: 24973892
[TBL] [Abstract][Full Text] [Related]
14. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
15. Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
17. [Association of CD133 and endothelin-converting enzyme expressions with prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Wang M; Wu C; Yang YQ; Chen J; Cao YK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):696-9. PubMed ID: 17545092
[TBL] [Abstract][Full Text] [Related]
18. High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer.
Huang M; Zhu H; Feng J; Ni S; Huang J
Dis Markers; 2015; 2015():986095. PubMed ID: 25691807
[TBL] [Abstract][Full Text] [Related]
19. Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer.
Gottschling S; Schnabel PA; Herth FJ; Herpel E
Cancer Genomics Proteomics; 2012; 9(5):275-86. PubMed ID: 22990107
[TBL] [Abstract][Full Text] [Related]
20. Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.
Li W; Tamamura R; Wang B; Liu Q; Liu H; Liu T; Katase N; Xiao J; Nagatsuka H
Biomed Res Int; 2014; 2014():132349. PubMed ID: 24804195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
